Figure 3. Kaplan-Meier estimates of survival for all 703 gliomas.
A. Progression free survival and overall survival among IDH1/2 mutant tumors stratified by relative Ki-67 expression level; B. Progression free survival and overall survival among IDH1/2 wild type tumors stratified by relative Ki-67 expression level.